Senzar Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Senzar Asset Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-70,668	Closed	-$3.83M	–	36
2018 Q1	$3.83M	Sell	70,668 -207,732	-75%	-$11.6M	1.21%	29
2017 Q4	$16.6M	Buy	278,400 +47,200	+20%	+$2.86M	4.25%	9
2017 Q3	$11.2M	Sell	231,200 -160,200	-41%	-$8.74M	2.74%	10
2017 Q2	$20.6M	Buy	+391,400	New	+$18.2M	5.06%	9
2017 Q1	–	Sell	-188,900	Closed	-$7.15M	–	33
2016 Q4	$7.15M	Buy	188,900 +96,700	+105%	+$3.66M	1.9%	17
2016 Q3	$3.48M	Buy	+92,200	New	+$2.03M	0.9%	29

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Senzar Asset Management's AERI Position: Q2 2018 in Review

Senzar Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2018, closing a stake of 70,668 shares — an estimated $3.83M sold.

Senzar Asset Management first reported a position in AERI in Q3 2016 and held it in 6 quarters. The position peaked at $20.6M in Q2 2017. 175 funds tracked by Wall St. Rank hold AERI as of Q2 2018.

Senzar Asset Management reported no remaining Aerie Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Senzar Asset Management sold 70,668 Aerie Pharmaceuticals shares in Q2 2018, an estimated $3.83M.
Senzar Asset Management first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 6 quarters.
Senzar Asset Management's Aerie Pharmaceuticals position peaked at $20.6M in Q2 2017.
175 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2018.

Based on Senzar Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.